Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | trihexyphenidyl | 5572 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | trihexyphenidyl | 5572 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | trihexyphenidyl | 5572 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | trihexyphenidyl | 5572 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | trihexyphenidyl | 5572 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | trihexyphenidyl | 5572 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | trihexyphenidyl | 5572 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | trihexyphenidyl | 5572 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | BCB000040 | None | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | BCB000040 | None | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | BCB000040 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | BCB000040 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | BCB000040 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | BCB000040 | None | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | BCB000040 | None | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | BCB000040 | None | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | BCB000040 | None | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | BCB000040 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | BCB000040 | None | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | BCB000040 | None | drug-path |